GSK allocates over $800 million to expand R&D and manufacturing hub in Pennsylvania
read at Endpoints ↗DealPositive
GSK announced it will invest more than $800 million to expand its presence in Pennsylvania, marking its second expansion in the state within two years.
The funds will be used to build a new research and development and manufacturing facility at its existing site, with construction slated to start in 2027.
The investment underscores GSK's commitment to strengthening its US manufacturing base and advancing its pipeline, though details on specific programs were not disclosed.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania”
read at Endpoints ↗79 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that